Amineptine induced liver injury. Report of two cases and brief review of the literature

Hepato-Gastroenterology

Volumn 43, Issue 10, 1996, Pages 1015-1019

  Lazaros, G A ^a   Stavrinos, C ^a   Papatheodoridis, G V ^a   Delladetsima, J K ^b   Toliopoulos, A ^a   Tassopoulos, N C ^a  

^a Western Attica General Hospital   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Adverse effects; Amineptine; Hepatic injury; Tricyclic antidepressants

Indexed keywords

AMINEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; DEPRESSION; FEMALE; GENETIC PREDISPOSITION; HUMAN; LIVER HISTOLOGY; LIVER INJURY; LIVER TOXICITY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DIAGNOSIS, DIFFERENTIAL; DIBENZOCYCLOHEPTENES; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER; MALE; TIME FACTORS;

EID: 0029797180     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Samarin R, Jori A, Bernasconi S, Morpugo E, Garattini S: Biochemical and pharmacological studies on amineptine (S1694) and (+) - amphetamine in the rat. J. Pharm. Pharmacol. 1977; 29: 555-558.
2. Domingo S, Marco S, Echebarria V: Hepatic and pancreatic injury associated with amineptine therapy. J. Clin. Gastroenterol. 1994; 18: 168-169.
3. Larrey D, Ruffer B, Pessayre D, Danan G, Algard M, Geneve J, Benhamou P: Cross hepatotoxicity between tricyclic antidepressants Gut 1986; 27: 726-727.
4. Geneve J, Larrey D, Pessayre D, Benhamou JP: Structure tricyclique des medicaments et hepatotoxicity. Gastroenterol. Clin. Biol. 1987; 11: 242-249.
5. Andrieu J, Doll J, Coffinier C: Hepatites dues a 1 amineptine: quatre observations. Gastroenterol. Clin. Biol. 1982; 6: 915-918.
6. Imbert Y, Ducos P, Griere G, Sanson V, Dupont E: Hepatite chronique cirrhogene a 1 amineptine? Gastroenterol. Clin. Biol. 1985; 9: 747-748.
7. Avignon JP, Dorval ED, Metman EH: Hepatotoxicite des antiadepresseurs: risque familial. Gastroenterol. Clin. Biol. 1984; 8: 766.
8. Larrey D, Berson A, Habersetzer F, Tinel M, Castot A, Babany G, Letteron P, Freneaux E, Loeper J, Dansetle P, Pessayre D: Genetic predisposition to drug hepatotoxicity: Role in hepatitis caused by Amineptine, a tricyclic antidepressant. Hepatology 1989; 10: 168-173.
9. Laurent-Puig P, Dussaix E, de Paillette L, Ducreux M, Pelletier G, Briantais MJ, Etinne JB, Buffet C: Prevalence of hepatitis C. virus PNA in suspected drug induced liver diseases J. Hepatol. 1993; 19: 487-489.
10. Ricca- Rosselini S, Grilli F, Gaudio M, Saragoni A, Miglio F: Hepatic injury associated with amineptine therapy. Ital. J. Gastroenterol. 1990; 22: 40-43.
11. Geneve J, Larrey D, Letteron P, Descatoir V, Tiuel M, Amouyal G, Pessayre D: Metabolic activation of the tricyclic antidepressant amineptine. I. Cytochrome P-450- mediated in vitro covalent binding. Biochem. Pharmacol. 1987; 36: 323-329.
12. Poignant JC: Revue pharmacologique sur l'amineptine. Encephale 1979; 5: 709-720.
13. Larrey D, Tinel M, Amouyal G, Freneaux E, Berson A, Fouin-Fortunet H, Babany G, Letteron P, Iglicki F, Slama JL, Habersetrer F, Pessayre D, Benhamon JP: Genetically determinated oxidation polymorphism and drug hepatotoxicity. Study of 51 patients. J. Hepatol. 1989; 8: 158-164.
14. Sherlock S: The spectrum of hepatotoxicity due to drugs. Lancet 1986; ii: 440-444.
15. Pessayre D, Larrey D: Acute and chronic drug induced hepatitis. Bailliers Clin. Gastroenterol. 1988; 2: 385-422.
16. Kupfer A, Preisig R: Inherited defects of hepatic drug metabolism. Semin. Liv. Dis. 1983; 3: 341-354.
17. Jacqz E, Hall SD, Branch RA: Genetically determinated polymorphisms in drug oxidation. Hepatology 1986; 6: 1020-1032.
18. Mahgoub A, Idle JR, Oring LG, Lancaster R, Smith RL: Polymorphic hydroxylation of debrisoquine in main. Lancet 1977; ii: 584-586.
19. Evans DAP, Mahgoub A, Sloan TP, Idle JR, Smith RL: A family population study of the genetic polymorphism of debrisoquine oxidation in a white English population. J. Med. Genet. 1980; 17: 102-105.
20. Benichou C: Criteria of drug-induced liver disease. Report of an International consensus meeting. J. Hepatol. 1990; 11: 272-276.